Sissel Rodahl
Corporate Officer/Principal bei GENSIGHT BIOLOGICS S.A.
Aktive Positionen von Sissel Rodahl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GENSIGHT BIOLOGICS S.A. | Corporate Officer/Principal | 31.01.2022 | - |
Karriereverlauf von Sissel Rodahl
Ehemalige bekannte Positionen von Sissel Rodahl
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | 01.09.2018 | 01.02.2022 |
Ausbildung von Sissel Rodahl
| University of Oslo | Graduate Degree |
| Engineering College | Undergraduate Degree |
Statistik
International
| Norwegen | 3 |
| Frankreich | 2 |
| Vereinigte Staaten | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENSIGHT BIOLOGICS S.A. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Börse
- Insiders
- Sissel Rodahl
- Erfahrung
